Showing 1 - 5 results of 5 for search 'Xiaotang Di' Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Author
  • Xiaotang Di
Showing 1 - 5 results of 5 for search 'Xiaotang Di', query time: 0.03s Refine Results
  1. 1
    Deubiquitinase OTUD3: a double-edged sword in immunity and disease

    Deubiquitinase OTUD3: a double-edged sword in immunity and disease by Qiao Xu, Lan He, Shubing Zhang, Xiaotang Di, Hao Jiang

    Published 2023-09-01
    Get full text
    Article
  2. 2
    Therapeutic potential of anti-PIK3CG treatment for multiple myeloma via inhibiting c-Myc pathway

    Therapeutic potential of anti-PIK3CG treatment for multiple myeloma via inhibiting c-Myc pathway by Xiaotang Di, Yiwen Pan, Jinhua Yan, Jing Liu, Doudou Wen, Hao Jiang, Shubing Zhang

    Published 2024-01-01
    Get full text
    Article
  3. 3
    Dissected subgroups predict the risk of recurrence of stage II colorectal cancer and select rational treatment

    Dissected subgroups predict the risk of recurrence of stage II colorectal cancer and select rational treatment by Fulong Wang, Shixun Lu, Xin Zhou, Xiaotang Di, Rujia Wu, Gong Chen, Sun Tian

    Published 2023-03-01
    Get full text
    Article
  4. 4
    Extracellular matrix marker LAMC2 targets ZEB1 to promote TNBC malignancy via up-regulating CD44/STAT3 signaling pathway

    Extracellular matrix marker LAMC2 targets ZEB1 to promote TNBC malignancy via up-regulating CD44/STAT3 signaling pathway by Ding Wang, Kailibinuer Keyoumu, Rongji Yu, Doudou Wen, Hao Jiang, Xinchun Liu, Xiaotang Di, Shubing Zhang

    Published 2024-05-01
    Get full text
    Article
  5. 5
    Targeting C21orf58 is a Novel Treatment Strategy of Hepatocellular Carcinoma by Disrupting the Formation of JAK2/C21orf58/STAT3 Complex

    Targeting C21orf58 is a Novel Treatment Strategy of Hepatocellular Carcinoma by Disrupting the Formation of JAK2/C21orf58/STAT3 Complex by Hao Jiang, Yang Wang, Doudou Wen, Rongji Yu, Sayed S Esa, Kefeng Lv, Qing Feng, Jing Liu, Faxiang Li, Lan He, Xiaotang Di, Shubing Zhang

    Published 2024-04-01
    Get full text
    Article

Search Tools:

  • RSS Feed
  • Email Search

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs